Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003143840 | SCV003830207 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2X | 2019-06-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004604931 | SCV005095648 | uncertain significance | Inborn genetic diseases | 2024-06-17 | criteria provided, single submitter | clinical testing | The c.263G>A (p.R88Q) alteration is located in exon 3 (coding exon 2) of the BVES gene. This alteration results from a G to A substitution at nucleotide position 263, causing the arginine (R) at amino acid position 88 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |